These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 2901058

  • 1. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
    Mori S, Fujitake J, Kuno S, Sano Y.
    Neurosci Lett; 1988 Jul 19; 90(1-2):57-62. PubMed ID: 2901058
    [Abstract] [Full Text] [Related]

  • 2. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
    Hadjiconstantinou M, Mariani AP, Neff NH.
    Brain Res; 1989 Apr 10; 484(1-2):297-303. PubMed ID: 2565752
    [Abstract] [Full Text] [Related]

  • 3. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
    Fuxe K, Janson AM, Rosén L, Finnman UB, Tanganelli S, Morari M, Goldstein M, Agnati LF.
    Exp Brain Res; 1992 Apr 10; 88(1):117-30. PubMed ID: 1347270
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues.
    Fries DS, de Vries J, Hazelhoff B, Horn AS.
    J Med Chem; 1986 Mar 10; 29(3):424-7. PubMed ID: 3485197
    [Abstract] [Full Text] [Related]

  • 5. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y, Watanabe A, Mori A, Koga N.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):660-3. PubMed ID: 9703982
    [Abstract] [Full Text] [Related]

  • 6. Difference in recovery patterns of striatal dopamine content, tyrosine hydroxylase activity and total biopterin content after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration: a comparison of young and older mice.
    Nishi K, Kondo T, Narabayashi H.
    Brain Res; 1989 Jun 05; 489(1):157-62. PubMed ID: 2568151
    [Abstract] [Full Text] [Related]

  • 7. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
    Araki T, Muramatsu Y, Tanaka K, Matsubara M, Imai Y.
    Neurosci Lett; 2001 Oct 12; 312(1):50-4. PubMed ID: 11578843
    [Abstract] [Full Text] [Related]

  • 8. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.
    Synapse; 2003 Jan 12; 47(1):10-4. PubMed ID: 12422368
    [Abstract] [Full Text] [Related]

  • 9. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM.
    J Neurosci Res; 2004 May 15; 76(4):539-50. PubMed ID: 15114626
    [Abstract] [Full Text] [Related]

  • 10. Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.
    Breidert T, Callebert J, Heneka MT, Landreth G, Launay JM, Hirsch EC.
    J Neurochem; 2002 Aug 15; 82(3):615-24. PubMed ID: 12153485
    [Abstract] [Full Text] [Related]

  • 11. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan 15; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB, Sturgess NC, Butt M, Wolf JC, Zadory D, Beck M, Mathews JM, Tisdel MO, Minnema D, Travis KZ, Cook AR, Botham PA, Smith LL.
    Neurotoxicology; 2013 Jul 15; 37():1-14. PubMed ID: 23523781
    [Abstract] [Full Text] [Related]

  • 13. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.
    Ricaurte GA, Langston JW, Delanney LE, Irwin I, Peroutka SJ, Forno LS.
    Brain Res; 1986 Jun 18; 376(1):117-24. PubMed ID: 3487376
    [Abstract] [Full Text] [Related]

  • 14. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK.
    Neurobiol Dis; 2012 Mar 18; 45(3):1051-67. PubMed ID: 22198503
    [Abstract] [Full Text] [Related]

  • 15. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion.
    Chadi G, Møller A, Rosén L, Janson AM, Agnati LA, Goldstein M, Ogren SO, Pettersson RF, Fuxe K.
    Exp Brain Res; 1993 Mar 18; 97(1):145-58. PubMed ID: 7907549
    [Abstract] [Full Text] [Related]

  • 16. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H, Hishida R, Hirata Y, Ono K, Suzuki H, Muramatsu S, Nakano I, Nagatsu T, Sawada M.
    J Neurosci Res; 2007 Jun 18; 85(8):1752-61. PubMed ID: 17469135
    [Abstract] [Full Text] [Related]

  • 17. Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway.
    Morgan WW, Nelson JF.
    Brain Res; 2001 Dec 07; 921(1-2):115-21. PubMed ID: 11720717
    [Abstract] [Full Text] [Related]

  • 18. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice.
    Otto D, Unsicker K.
    J Neurosci; 1990 Jun 07; 10(6):1912-21. PubMed ID: 1972393
    [Abstract] [Full Text] [Related]

  • 19. Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice.
    Sundström E, Strömberg I, Tsutsumi T, Olson L, Jonsson G.
    Brain Res; 1987 Mar 03; 405(1):26-38. PubMed ID: 2882814
    [Abstract] [Full Text] [Related]

  • 20. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity.
    Mayer RA, Walters AS, Heikkila RE.
    Eur J Pharmacol; 1986 Jan 29; 120(3):375-7. PubMed ID: 2868908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.